等待开盘 12-19 09:30:00 美东时间
+4.930
+3.08%
今日重点评级关注:富国银行:维持Milestone Pharmaceuticals"超配"评级,目标价从4美元升至8美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从31美元升至33美元
12-17 10:46
The November 2025 Cass Transportation Index report indicated that the freight market has stabilized after a prolonged downturn, with mixed signals across shipments, expenditures, and truckload pricing...
12-16 23:00
Barclays analyst Brandon Oglenski upgrades C.H. Robinson Worldwide (NASDAQ:CHRW) from Equal-Weight to Overweight and raises the price target from $145 to $200.
12-16 21:33
This whale alert can help traders discover the next big trading opportunities. ...
12-16 01:35
今日重点评级关注:Ascendiant Capital:维持GRI Bio"买入"评级,目标价从35美元升至36美元;Ascendiant Capital:维持Atossa Therapeutics"买入"评级,目标价从7.75美元升至8美元
12-09 10:32
Morgan Stanley analyst Ravi Shanker maintains C.H. Robinson Worldwide (NASDAQ:CHRW) with a Underweight and raises the price target from $77 to $85.
12-09 01:12
Goldman Sachs says investors are shifting toward companies quietly using AI to cut costs and drive productivity-led growth.
11-17 23:47
The Federal Aviation Administration’s directive to trim flight capacity by 10% across 40 major U.S. airports could tighten air cargo networks just as the holiday shipping season begins, the Associated...
11-09 21:23
今日重点评级关注:康托·菲茨杰拉德:维持Cabaletta Bio"超配"评级,目标价从15美元升至30美元;HC Wainwright & Co.:维持Invivyd"买入"评级,目标价从5美元升至10美元
11-03 20:20
今日重点评级关注:Ascendiant Capital:维持NRX Pharmaceuticals"买入"评级,目标价从46美元升至47美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从27美元升至31美元
10-31 10:25